Items where Author is "Sheibani, M."

Article

(2025) Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2). Innovative Medicine of Kuban. pp. 101-109. ISSN 25419897 (ISSN)

(2024) Doxorubicin-related cardiotoxicity: review of fundamental pathways of cardiovascular system injury. Cardiovascular Pathology. p. 13. ISSN 1054-8807

(2024) Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1). Innovative Medicine of Kuban. pp. 126-135. ISSN 25419897 (ISSN)

(2023) Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity. Innovative Medicine of Kuban. pp. 6-14. ISSN 25419897 (ISSN)

(2023) HIV-Related Atherosclerosis: State- of-the-Art-Review. Current Problems in Cardiology. p. 18. ISSN 0146-2806

(2023) Possibilities of dapagliflozin-induced cardioprotection on doxorubicin plus cyclophosphamide mode of chemotherapy-induced cardiomyopathy. International Journal of Cardiology. p. 9. ISSN 0167-5273

(2022) AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study. CURRENT PROBLEMS IN CARDIOLOGY. ISSN 01462806 (ISSN)

(2022) AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study Zinaida Jndoyanj. Current Problems in Cardiology. p. 6. ISSN 0146-2806